0001021771-24-000050.txt : 20240215
0001021771-24-000050.hdr.sgml : 20240215
20240215161945
ACCESSION NUMBER: 0001021771-24-000050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240213
FILED AS OF DATE: 20240215
DATE AS OF CHANGE: 20240215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paccasassi Robert
CENTRAL INDEX KEY: 0001751339
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37603
FILM NUMBER: 24644075
MAIL ADDRESS:
STREET 1: C/O BIORESTORATIVE THERAPIES, INC.
STREET 2: 40 MARCUS DRIVE, SUITE 1
CITY: MELVILLE
STATE: NY
ZIP: 11747
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioRestorative Therapies, Inc.
CENTRAL INDEX KEY: 0001505497
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 301341024
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MARCUS DRIVE
CITY: MELVILLE
STATE: NY
ZIP: 11747
BUSINESS PHONE: (631) 760-8100
MAIL ADDRESS:
STREET 1: 40 MARCUS DRIVE
CITY: MELVILLE
STATE: NY
ZIP: 11747
FORMER COMPANY:
FORMER CONFORMED NAME: Stem Cell Assurance, Inc.
DATE OF NAME CHANGE: 20101110
4
1
form4.xml
X0508
4
2024-02-13
0001505497
BioRestorative Therapies, Inc.
BRTX
0001751339
Paccasassi Robert
C/O BIORESTORATIVE THERAPIES, INC.
40 MARCUS DRIVE, SUITE ONE
MELVILLE
NY
11747
true
VP, QA and Reg Compliance
false
Stock Option
5.08
2031-11-04
Common Stock
8277
8277
D
Stock Option
2.91
2033-02-17
Common Stock
88968
88968
D
Stock Option
1.45
2024-02-13
4
A
0
219298
0
A
2034-02-13
Common Stock
219298
219298
D
The option is currently exercisable.
The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.
The option vests and becomes exercisable to the extent of 109,649 shares on February 13, 2024 with the remaining 109,649 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested.
/s/ Robert Paccasassi
2024-02-13